Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory

We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on Value investing subreddit by Significant-Foot3928. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc.’s share was trading at $589.48 as of August 22nd. REGN’s trailing and forward P/E were 14.86 and 16.18 respectively according to Yahoo Finance.

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

kurhan / shutterstock.com

Regeneron Pharmaceuticals operates as a fully integrated biotech, designing, developing, manufacturing,...